Madrigal Pharmaceuticals
Price & Volume
Stats
See more52W Range | $189-$377.46 |
Market Cap | $7.6B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $180.1M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $173.9M |
Diluted EPS | -$21.91 |
News
See moreYahoo Finance • 7 days ago
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors
Yahoo Finance • 19 days ago
Madrigal Pharmaceuticals Inc (MDGL) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ...
Yahoo Finance • 20 days ago
Madrigal Announces New Two-Year Data from the Compensated MASH Cirrhosis Arm of the MAESTRO-NAFLD-1 Trial Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH Cirrhosis
Yahoo Finance • 25 days ago
Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference
About
CEO | Mr. William J. Sibold |
CFO | Ms. Mardi C. Dier |
Address | Four Tower Bridge, West Conshohocken, PA, United States, 19428 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 528 |
